From The Tribune
Center Owned by The Tribune TrustRevised cancer drug prices kick in, patients set to save Rs 3,540 cr
What's behind this
The National Pharmaceutical Pricing Authority has capped trade margins on the maximum retail prices of 137 anti‑cancer drugs, with the revised prices taking effect from Monday. The move is projected to save consumers about Rs 3,540 crore each year. For example, the cost of a month’s supply of anastrozole 1 mg for a breast‑cancer patient in Bengaluru is expected to fall from roughly ₹2,087 to ₹219 from November 9. Oncologists view the reduction as a significant benefit for families, though they stress it is only a first step toward broader access.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
center · 3 outlets
New Delhi, November 9 (IANS): The government on Monday said revised prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.The National Pharmaceutical…
RSS excerpt
Prices of 137 anti-cancer drugs have been reduced with effect from Monday after the National Pharmaceutical Pricing Authority (NPPA) capped trade margins on their maximum retail prices (MRPs), a move expected to save consumers around Rs 3,540 crore annually. The price revision follows…
